Use of a Neurometabolism-Targeting Drug in Prevention of Postoperative Cognitive Dysfunction

   Aim of the study: to evaluate the feasibility of preventing cognitive dysfunction after long-term surgery in elderly patients using an original neurometabolic succinate-containing drug.
   Material and methods. A multicenter, double-blind, placebo-controlled randomized trial enrolled 200 patients aged 60–80 years who underwent elective cardiac or orthopedic surgery. The patients received either the study drug (inosine + nicotinamide + riboflavin + succinate) (treatment group, n = 101) or a placebo (control group, n = 99) intravenously for 7 days then orally for 25 days. Efficacy was assessed by the change in the Montreal Cognitive Assessment Scale (MoCA) score at the end of the treatment course compared with the preoperative level.
   Results. Before surgery, the total MoCA score values did not differ between the groups. By the end of the treatment course (31 days after surgery), the MoCA total score was 26.4 ± 1.96 in the main group and 25.0 ± 2.83
in the control group (P < 0.001). The intergroup difference in the mean change in the MoCA total score on day 31 was 1.56 points (95 % CI 1.015; 2.113; P < 0.0001) favoring the study drug in all randomized population. The lower limit of CI (1.015) exceeded the limit of superiority set by the protocol (0.97 points), which allowed acceptance of the hypothesis of superiority of the study drug over placebo with respect to the primary efficacy criterion. No significant differences in the frequency of adverse events were found between the groups.
   Conclusion. The succinate-containing study drug demonstrated an acceptable safety profile and helped to reduce the severity of postoperative cognitive dysfunction in elderly patients who underwent a major surgery, which allows recommending the drug for prevention of postoperative cognitive impairment in high-risk patients.

1. Mashour G. A., Woodrum D. T., Avidan M. S. Neurological complications of surgery and anaesthesia. Br J Anaesth. 2015; 114 (2): 194–203. DOI: 10.1093/bja/aeu296.

2. Steinmetz J., Christensen K.B., Lund T., Lohse N., Rasmussen L.S., ISPOCD Group. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology. 2009; 110 (3): 548–555. DOI: 10.1097/ALN.0b013e318195b569.

3. Field R. R., Wall M. H. Delirium: past, present, and future. Semin Cardiothorac Vasc Anesth. 2013; 17 (3): 170–179. DOI: 10.1177/1089253213476957.

4. Rudolph J. L., Schreiber K. A., Culley D. J., McGlinchey R. E., Crosby G., Levitsky S., Marcantonio E. R. Measurement of post-operative cognitive dysfunction after cardiac surgery: a systematic review. Acta Anaesthesiol Scand. 2010; 54 (6): 663–677. DOI: 10.1111/j.1399-6576.2010.02236.x.

5. Funder K. S., Steinmetz J., Rasmussen L. S. Cognitive dysfunction after cardiovascular surgery. Minerva Anestesiol. 2009; 75 (5): 329–332.

6. Guay J. General anaesthesia does not contribute to long-term postoperative cognitive dysfunction in adults: a meta-analysis. Indian J Anaesth. 2011; 55 (4): 358–363. DOI: 10.4103/0019-5049.84850.

7. Feinkohl I., Winterer G., D. Spies C., Pischon T. Cognitive reserve and the risk of postoperative cognitive dysfunction. Dtsch Ärztebl Int. 2017; 114 (7): 110–117. DOI: 10.3238/arztebl.2017.0110.

8. Jones R. N., Fong T. G., Metzger E., Tulebaev S., Yang F. M., Alsop D. C. Aging, brain disease, and reserve: implications for delirium. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2010; 18 (2): 117–127. DOI: 10.1097/JGP.0b013e3181b972e8.

9. Овезов А. М. Церебропротекция в профилактике ранней послеоперационной когнитивной дисфункции при тотальной внутривенной анестезии / А. М. Овезов [и др.] // Лечащий врач. – 2013. – (3).

10. Кардаш О. Ф. Влияние цитофлавина на восстановление когнитивных функций после операции на сердце в условиях искусственного кровообращения / О. Ф. Кардаш [и др.] // Журнал неврологии и психиатрии им. С. С. Корсакова. – 2011/ – 111 (7): 76–79.

11. Суслина З. А. Нейропротекция в кардиохирургии / З. А. Суслина [и др.] // Анналы клинической и экспериментальной неврологии. – 2009. – 3 (1): 4–8.

12. Nasreddine Z. S., Phillips N. A., Bédirian V., Charbonneau S., Whitehead V., Collin I., Cummings J. L., Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53 (4): 695–699. DOI: 10.1111/j.1532-5415.2005.53221.x.

13. Folstein M. F., Folstein S. E., McHugh P. R. «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12 (3): 189–198. DOI: 10.1016/0022-3956(75)90026-6.

14. ASA Physical Status Classification System. American Society of Anesthesiologists; 2020.

15. Murkin J. M., Newman S. P., Stump D. A., Blumenthal J. A. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg. 1995; 59 (5): 1289–1295. DOI: 10.1016/0003-4975(95)00106-u.

16. Sutton R., Bann S., Brooks M., Sarin S. The Surgical Risk Scale as an improved tool for risk-adjusted analysis in comparative surgical audit. British Journal of Surgery. 2002; 89 (6): 763–768. DOI: 10.1046/j.1365-2168.2002.02080.x.

17. Rudolph J. L., Jones R. N., Levkoff S. E., Rockett C., Inouye S. K., Sellke F. W., Khuri S. F., Lipsitz L. A., Ramlawi B., Levitsky S., Marcantonio E. R. Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery. Circulation. 2009; 119 (2): 229–236. DOI: 10.1161/CIRCULATIONAHA.108.795260.

18. Rockwood K., Andrew M., Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007; 62 (7): 738–743. DOI: 10.1093/gerona/62.7.738.

19. EQ-5D-3L – EQ-5D [Интернет]. Доступно на: https: //euroqol.org/eq-5d-instruments/eq-5d-3l-about/.

20. Djukanovic I., Carlsson J., Årestedt K. Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65–80 years old? A psychometric evaluation study. Health Qual Life Outcomes. 2017; 15 (1): 193. DOI: 10.1186/s12955-017-0759-9.

21. Shelkey M., Wallace M. Katz Index of Independence in Activities of Daily Living. Home Healthcare Nurse. 2001; 19 (5): 323–324.

22. Bilotta F., Gelb A. W., Stazi E., Titi L., Paoloni F. P., Rosa G. Pharmacological perioperative brain neuroprotection: a qualitative review of randomized clinical trials. Br J Anaesth. 2013; 110: 113–120. DOI: 10.1093/bja/aet059.

23. Borchers F., Spies C. D., Feinkohl I., Brockhaus W.-R., Kraft A., Kozma P., Fislage M., Kühn S., Ionescu C., Speidel S., Hadzidiakos D., Veldhuijzen D. S., Yürek F., Evered L. A., Ottens T. H. Methodology of measuring postoperative cognitive dysfunction: a systematic review. Br J Anaesth. 2021; 126 (6): 1119–1127. DOI: 10.1016/j.bja.2021.01.035.

24. Тарасова И. В. Гендерные особенности когнитивных функций, оцененных шкалами MMSE и MоCA, у пациентов с ишемической болезнью сердца / И. В. Тарасова [и др.] // Российский кардиологический журнал. – 2021. – 26 (2): 11–17

25. Moller J. T., Cluitmans P., Rasmussen L. S., Houx P., Rasmussen H., Canet J., Rabbitt P., Jolles J., Larsen K., Hanning C. D., Langeron O., Johnson T., Lauven P. M., Kristensen P. A., Biedler A., van Beem H., Fraidakis O., Silverstein J. H., Beneken J. E., Gravenstein J. S. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet Lond Engl. 1998; 351 (9106): 857–861.

26. Berger M., Nadler J. W., Browndyke J., Terrando N., Ponnusamy V., Cohen H. J., Whitson H. E., Mathew J. P. Postoperative Cognitive Dysfunction: Minding the Gaps in Our Knowledge of a Common Postoperative Complication in the Elderly. Anesthesiol Clin. 2015; 33 (3): 517–550. DOI: 10.1016/j.anclin.2015.05.008.

27. Patel N., Minhas J. S., Chung E. M. L. Risk Factors Associated with Cognitive Decline after Cardiac Surgery: A Systematic Review. Cardiovasc Psychiatry Neurol. 2015; 2015: 370612. DOI: 10.1155/2015/370612.